An unusual presentation of scleromyxedema as inflammatory myopathy

Acta Myol. 2019 Mar 1;38(1):13-16. eCollection 2019 Mar.

Abstract

Scleromyxedema is a rare cutaneous mucinosis with frequent extracutaneous manifestations. Myopathy in scleromyxedema is a poorly recognized syndrome among neurologists and can mimic idiopathic and connective tissue disease-associated inflammatory myopathy. Diagnosis is suspected by the characterization of the skin lesions and clinched by skin and muscle biopsies. Here, we report a patient with scleromyxedema and myopathy with the characteristic histopathological feature of mucin deposition in skin biopsy. Her muscle biopsy showed a picture consistent with scleromyxedema myopathy with vacuolar and inflammatory changes. The association with paraproteinemia, propensity to life-threatening central nervous system disease and good response to intravenous immunoglobulin necessitate the accurate diagnosis of this condition.

Keywords: inflammatory myopathy; monoclonal gammopathy; scleroderma; scleromyxedema; vacuolar myopathy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Biopsy
  • Diagnosis, Differential
  • Drug Therapy, Combination
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunosuppressive Agents / therapeutic use
  • Myositis / diagnosis*
  • Myositis / drug therapy
  • Prednisolone / therapeutic use
  • Scleromyxedema / diagnosis*
  • Scleromyxedema / drug therapy
  • Thalidomide / therapeutic use

Substances

  • Glucocorticoids
  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents
  • Thalidomide
  • Prednisolone